Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of Depression in Adults
Gregory E. Simon, Nathalie Moise, David C. Mohr
JAMA (2024) Vol. 332, Iss. 2, pp. 141-141
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Demographic and clinical predictors of response and remission in the treatment of major depressive disorder with ketamine and esketamine: A systematic review
Juliana Lima Constantino, Michael Godschalk, Jens H. van Dalfsen, et al.
Psychiatry Research (2025) Vol. 345, pp. 116355-116355
Open Access
Unveiling the significance of AKAP79/150 in the nervous system disorders: An emerging opportunity for future therapies?
Chen-Chao Chu, Yahui Hu, Gui-Zhou Li, et al.
Neurobiology of Disease (2025), pp. 106812-106812
Open Access
Exploring the active components and potential mechanisms of Zhimu-Huangbai herb-pair in the treatment of depression
Xia Lei, Deping Zhao, T. Chen, et al.
Phytomedicine (2025), pp. 156365-156365
Closed Access
Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches
Aline Silva de Miranda, Eliana Cristina de Brito Toscano, Venugopal Reddy Venna, et al.
Expert Opinion on Drug Discovery (2025), pp. 1-15
Closed Access
Property-Based Design of Xanthine Derivatives as Potent and Orally Available TRPC4/5 Inhibitors for Depression and Anxiety
Zhaoxiang Song, Huaduan Liang, Chu Xue, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Joint association of sleep onset time and sleep duration with depression in patients with chronic kidney disease: Insights from the NHANES 2015–2020
Kaiying He, Shaoqiang Guo, Juan Zhu, et al.
Preventive Medicine Reports (2025) Vol. 51, pp. 103006-103006
Open Access
Discovery and validation of CREB1 as a transcription target of icaritin: Implications for the treatment of depressive-like behavior
Ling Gu, Lei Li, Huiying Xu, et al.
Brain Research Bulletin (2025), pp. 111264-111264
Open Access
Challenges in Managing Depression in Clinical Practice: Result of a Global Survey
Nilamadhab Kar
Pharmacoepidemiology (2025) Vol. 4, Iss. 1, pp. 5-5
Open Access
Efficacy of dynamic interpersonal therapy in improving mentalising in patients with major depressive disorder and the mediating effect of mentalising on changes in depressive symptoms
Wenhui Jiang, Jiayu Yao, Yuan Wang, et al.
General Psychiatry (2025) Vol. 38, Iss. 1, pp. e101774-e101774
Open Access
Sex Hormone Fluctuations as a Precursor to Depression in Females But Not Males
Jialing Zhang, Yong Yang, Yunpeng Li, et al.
(2025)
Closed Access
Personalising Antidepressant Treatment for Unipolar Depression Combining Individual Choices, Risks and big Data: The PETRUSHKA Tool: Personnalisation du traitement antidépresseur de la dépression unipolaire associant choix individuels, risques et mégadonnées: l’outil PETRUSHKA
Edoardo G. Ostinelli, Matt Jaquiery, Qiang Liu, et al.
The Canadian Journal of Psychiatry (2025)
Closed Access
The involvement of the microbiota-gut-brain axis in the pathophysiology of mood disorders and therapeutic implications
Izabela Guimarães Barbosa, Aline Silva de Miranda, Michael Berk, et al.
Expert Review of Neurotherapeutics (2024)
Closed Access | Times Cited: 2
Management of Depression
Raffaele Antonelli Incalzi, Siegfried Kasper, Pedro Morgado
JAMA (2024) Vol. 332, Iss. 19, pp. 1673-1673
Closed Access | Times Cited: 2
Drug–Drug Interactions of Selective Serotonin Reuptake Inhibitors: A Pharmacovigilance Study on Real-World Evidence from the EudraVigilance Database
Carmen Maximiliana Dobrea, Adina Frum, Anca Butucă, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1278-1278
Open Access | Times Cited: 1
Depressive symptoms and its relation to all-cause and cardiovascular mortality among United States adults with different diabetic status
Hua-Zhao Xu, Xiangda Meng, Qian Liu, et al.
The International Journal of Psychiatry in Medicine (2024)
Closed Access | Times Cited: 1
The effect of virtual reality-based rehabilitation on mental health and quality of life of stroke patients: a systematic review and meta-analysis of randomized controlled trials
Saikun Wang, Hongdao Meng, Yong Zhang, et al.
Archives of Physical Medicine and Rehabilitation (2024)
Closed Access | Times Cited: 1
Management of Depression
Anders Jorgensen, Charles H. Kellner, Martin Balslev Jørgensen
JAMA (2024) Vol. 332, Iss. 19, pp. 1672-1672
Closed Access
Management of Depression
Toshi A. Furukawa
JAMA (2024) Vol. 332, Iss. 19, pp. 1674-1674
Closed Access
Beyond Detection: Towards Actionable Sensing Research in Clinical Mental Healthcare
Daniel A. Adler, Yuewen Yang, Thalia Viranda, et al.
Proceedings of the ACM on Interactive Mobile Wearable and Ubiquitous Technologies (2024) Vol. 8, Iss. 4, pp. 1-33
Open Access
Sleep deprivation activated AMPK/FOXO3a signaling mediates pineal autophagy impairment to reduce melatonin secretion in CUMS + SD rats leading to depression combined with insomnia
Zirong Li, Yi Shu, Qian Liu, et al.
Neuroscience Letters (2024), pp. 138091-138091
Open Access
Effect of bariatric surgery on nutritional and metabolic parameters: does the type of antidepressant medication matter?
Katherine J. P. Schwenger, Yasaman Ghorbani, Fadi Alkass, et al.
Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity (2024) Vol. 29, Iss. 1
Open Access
Error in Discussion Section

JAMA (2024) Vol. 332, Iss. 15, pp. 1306-1306
Open Access
Management of Depression
S. Shalom Feinberg
JAMA (2024) Vol. 332, Iss. 19, pp. 1673-1673
Closed Access
An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United States
Syed F. Rab, Charles L. Raison, Elliot Marseille
Psychedelics. (2024), pp. 1-5
Closed Access
Fat-Soluble Vitamins Mediate the Association between Biological Aging and Depression
Huaisha Xu, Jiayuan Tu, Yongzhuang Chen, et al.
(2024)
Closed Access
Page 1 - Next Page

Scroll to top